SlideShare a Scribd company logo
Prepared By: Vipin Kr. Shukla
Assistant Lecturer
Presentation on COVID-19
Introduction of COVID-19:
 It is the infectious and communicable disease caused by the
newly developed virus CORONA (COVID-19), which is
characterized by flu, cough, sore throat, fever, severe acute
respiratory syndrome and pneumonia.
 COVID-19 is a disease caused by a type of corona virus called
“ Sars Cov2”.
 The name corona came from its crown like structure called
“Spike Protein”.
 The Virus uses the spike protein to infect human cells.
Contd….
 Corona viruses (CoV) are a large family of viruses that cause
illness ranging from the common cold to more severe diseases
such as Middle East Respiratory Syndrome.
 (MERS-CoV) and Severe Acute Respiratory Syndrome
(SARS-CoV).
 A novel corona virus (nCoV) is a new strain that has not been
previously identified in humans
Origin
Wuhan City, Hubei Province, China.
STRUCTURE OF SARS-COV2:
Causes:
 The main cause of this disease is newly developed virus
CORONA, COVID-19 virus.
 The name corona virus comes from the Latin word corona,
meaning crown or halo.
 Under an electron microscope, the looks like it is surrounded
by a solar corona.
 First time COVID-19 discovered in a seafood and poultry
market in the Chinese city of Wuhan in 2019.
Symptoms of (COVID-19):
Mode of transmission:
 COVID-19 transmitted through respiratory droplet and 2-14
days estimated incubation period.
 Humans first get a corona virus from contact with animals.
Then, it can spread from human to human.
 Health officials do not know what animal caused COVID -19
 The COVID-19 virus can be spread through contact with
certain body fluids, such as droplets in cough.
 It might also be caused by touching something an infected
person has touched and then touching your hand to your
mouth, nose or eyes.
MODES OF TRANSMISSION:
People who are at higher risk:
 People aged 65 years and older.
 People who live in a nursing home or long-term care facility.
 Other high-risk conditions could include:
 People with chronic lung disease or moderate to severe asthma
 People who have serious heart conditions
 People who are immuno-compromised including cancer
treatment, smoking, bone marrow or organ.
 transplantation, immune deficiencies, poorly controlled HIV or
AIDS, and prolonged use of corticosteroids and other immune
weakening medications.
WHY IT IS TERMED AS PANDEMIC??
On March 11, 2020 WHO announced
COVID- 19 as a pandemic which
indicated that the spread of this
novel virus has become a worldwide
phenomenon, which has infected
almost 200 countries and territories
around the world including INDIA
and there are almost 2,407,699
confirmed cases of coronavirus
COVID-19.
PREVENTION--- WHAT TO DO???
 Wash your hands often with soap and
water for 20 seconds.
 Use a hand sanitizer (at least 70%
alcohol based) if soap and water are
not available and cover all the
surfaces of your hands.
 DO USE a handkerchief or a tissue
to cover your face while coughing or
sneezing.
 DO THROW the used tissue
immediately into a closed dustbin.
Do cover your sneeze
into your bent arm in
case you are not
carrying a tissue or a
handkerchief.
Do wash hands
immediately after you
have covered your
sneeze or cough with
your hands.
Stay at home
unless absolutely
necessary.
Keep a distance of
at least one meter
between yourself
and another
person.
WHAT NOT TO DO???
Do not touch your eyes, nose
and mouth with unwashed
hands.
Do not touch surfaces like
door knobs, door bells,
elevator button, handrails etc.
Do not spit in open, always
use a spittoon or wash basin
for spitting.
Do not go to crowded places
like markets, shopping, fairs,
parties.
Do not use public transport.
Do not hold events where
people have to gather.
High Risk:
People who have
underlying medical
conditions like:
• Diabetes.
• Heart Disease.
• Lung Disease.
• Kidney Disease.
• Cancer Medication
Pregnant Women
(as we don’t
know
the impact of the
disease on
Pregnancy, it is
better to take
care
MYTHS AND FACTS…
 Statement: With the summers coming up, the Corona virus will
be killed.
 FACT: COVID-19 has been detected in ALL AREAS,
including areas with hot and humid weather. The best way to
protect yourself against COVID- 19 is by frequently washing
your hands with soap and water, covering your coughs and
sneezes and avoiding crowded places.
 Statement: Having a bath with hot water will kill the virus.
 FACT: The virus lives inside the body where the temperature
is maintained at 37ºC and is not affected by a hot water bath
that you have.
 Statement: Getting the pneumonia vaccine will protect you
against the virus.
 FACT: While vaccines for Pneumonia will certainly protect
you against other organisms that cause pneumonia, The vaccine
for Novel Corona virus is under development.
Contd….
 Statement: Regularly rinsing the nose with saline will prevent
the infection.
 FACT: Rinsing nose with saline has in few cases helped in
containing common cold, but has no evidence to suggest it is
effective against the Novel Corona virus infection.
 Statement: Corona virus can be passed through chicken and
meat.
 FACT: No! There is no such evidence of Corona virus
spreading through meat and poultry products. However it is
always advised to have properly cooked meat and chicken.
Contd….
 Statement: Eating raw garlic, sesame seeds will protect you
against the virus.
 FACT: Garlic is a healthy food that has other benefits but does
not protect you against the Corona virus.
 Statement: You can get COVID-19 through mosquito bites.
 FACT: The Corona virus cannot be spread through the bite of a
mosquito. It is spread thorough droplets spread when an
infected person sneezes or coughs.
Some other consequences of COVID-19:
 STIGMA
 DISCRIMINATION
 DEPRESSION
Why there is stigma??
 The level of stigma associated with COVID-19 is based on three
main factors:
 COVID-19 is a new disease about which many things are still being
discovered.
 When something is unknown people are worried which leads to
fear.
 Rumors or fake news give wrong information and spreads the fear.
WHAT DOES STIGMA DO???
It is the time not to be
afraid but need to get
aware…
Follow all the advices
either prescribed by the
health department or
by the government…
Be a responsible citizen.
Stay At Home, Stay Safe,
Stay Healthy and
Happy…
Most Important Points….
 Always Be Positive.
 Do not preach or give news that is not confirmed.
 Always be polite. Anyone can get the infection. Do
not discriminate, shout, or use rude language.
 Stay away from watching negative things on TV and
also fake news.
 Engage in relaxing activities like indoor games,
reading, gardening, home-cleaning etc.
 Do Meditation, pray to GOD and spend some time
with yourself also.
Some great persons said…
So powerful is the
light of unity that
it can illuminate
the whole earth.
Even the weak
become strong
when they are
united.
So to beat this worldwide
pandemic, we all have to come
together and fulfill our respective
responsibilities.
Covid Vaccine :
Recent news on vaccine:
 India has so far approved three vaccines against the deadly COVID-19
to be used for its inoculation drive which started on January 16.
 The three vaccines approved by the Health Ministry are Serum Institute
of India's (SII) Covishield, Bharat Biotech's Covaxin and Russia's
Sputnik V.
 While Covaxin and Covishield are available since the vaccination drive
started in January, Russia's Sputnik V got the government's approval last
week and will now be distributed by Dr Reddy’s Laboratories in India.
With this, Sputnik V also became the second most expensive COVID-19
vaccine available in the country.
….
 University and pharma major AstraZeneca, the Covaxin has been
developed by India's Bharat Biotech in association with the Indian
Council of Medical Research (ICMR).
 The Sputnik V has been developed by Moscow-based Gamaleya
Research Institute of Epidemiology and Microbiology, and like most
vaccines, it also needs to be administered in two doses.
 As the world's biggest vaccination drive is underway, there is a lot of
buzzes that surrounds the use of the vaccines, it's efficacy and possible
side effects.
 We at Jagran English bring you some noteworthy differences between
the three vaccines available in India you must be aware of.
Introduction:
 A COVID-19 vaccine is a vaccine intended to
provide acquired immunity against severe acute respiratory
syndrome corona virus 2 (SARS-CoV-2), the virus
causing corona virus disease 2019 (COVID-19).
 Prior to the COVID-19 pandemic, there was an established
body of knowledge about the structure and function of corona
viruses causing diseases like severe acute respiratory
syndrome (SARS) and Middle East respiratory
syndrome (MERS), which enabled accelerated development of
various vaccine technologies during early 2020.
Contd….
 On 10 January 2020, the SARS-CoV-2 genetic sequence data
was shared through GISAID and by 19 March, the global
pharmaceutical industry announced a major commitment to
address COVID-19.
 Since January 2020, vaccine development has been expedited
via unprecedented collaboration in the multinational
pharmaceutical industry and between governments.
Contd….
 According to the Coalition for Epidemic Preparedness Innovations (CEPI),
 the geographic distribution of COVID-19 vaccine development puts North American
entities having about 40% of the activity compared to 30% in Asia and Australia, 26% in
Europe, and a few projects in South America and Africa.
 As of January 2021, nine different technology platforms – with the technology of
numerous candidates remaining undefined – are under research and development to
create an effective vaccine against COVID-19.
 Most of the platforms of vaccine candidates in clinical trials are focused on the corona
virus spike protein and its variant as the primary antigen of COVID-19 infection.
 Platforms being developed in 2020 involved nucleic acid technologies (nucleoside-
modified messenger RNA and DNA non-replicating viral vectors, peptides, recombinant
proteins, live attenuated viruses, and inactivated viruses.
Types of Vaccines:
 An RNA vaccine contains RNA which, when introduced into a
tissue, acts as messenger RNA (mRNA) to cause the cells to
build the foreign protein and stimulate an adaptive immune
response which teaches the body how to identify and destroy
the corresponding pathogen or cancer cells.
 RNA vaccines often, but not always, use nucleoside-modified
messenger RNA.
 The delivery of mRNA is achieved by a co formulation of the
molecule into lipid nanoparticles which protect the RNA
strands and help their absorption into the cells.
Comparison Between Covaxin & Covishield:
COVID VACCINE REGISTRATION:
WHO CAN REGISTER?
 Senior Citizens
(age 60+).
 People with co-
morbidities (age
45 to 59).
 18+ Individuals.
WHAT’S THE COST?
 People walking in private health
facilities – INR 250/-
 includes syringe.
 Needle.
 Fees for National Health
Accounts Govt of India.
 Govt Centers: Free of Cost.
Contd….
 PRE-REQUISITES:
 Co-Win App
 Aarogya Setu App
 Way to logon to cowin.gov.in
 Doctors certificate in case of Co-morbidities
Step By Step Guide for Registration:
 Open one of the below
 Co-Win App.
 Aarogya Setu App.
 visit www.cowin.gov.in.
 Enter your mobile number.
 You will receive OTP i.e. One Time Password on your mobile.
 Create account using OTP.
 Fill below details:
 Name.
 Age.
 Gender.
 Identification proof.
 Doctors certificate in case of co-morbidities & age 45 to 59.
 Choose your vaccine centre & Date.
Covishield Vs Covaxin:
 The interval between 1st and 2nd
doses is 12-16 weeks.
 Efficacy after the second dose can
vary from 70-90%.
 People above 18 years of age can
opt for this vaccine.
 Covishield is less expensive. SII is
selling this vaccine at INR 300
(government) and INR 600 (private
centers).
 Covishield is more easily available
 The interval between the 2 doses
is 4-6 weeks.
 This vaccine can be 78-100%
effective after the second dose.
 This vaccine can be injected into
younger people as well (12 years
and above).
 Covaxin is more expensive and
is being sold at INR 400
(government) and INR 1200
(private facilities).
 Fewer hospitals and healthcare
centers are stocking Covaxin
Presentation on covid 19

More Related Content

What's hot

COVID-19 I Coronavirus Disease I Harshit Jadav
COVID-19 I Coronavirus Disease I Harshit JadavCOVID-19 I Coronavirus Disease I Harshit Jadav
COVID-19 I Coronavirus Disease I Harshit Jadav
Harshit Jadav
 
Covid 19
Covid 19Covid 19
Covid 19
AvinandanPal2
 
Corona virus
Corona virusCorona virus
Corona virus
Hassam Ahmad
 
Corona virus COVID19
Corona virus COVID19Corona virus COVID19
Corona virus COVID19
HARINATHA REDDY ASWARTHA
 
COVID-19
COVID-19 COVID-19
COVID-19
Partha sarathi
 
COVID 19
COVID 19  COVID 19
COVID 19
Gamal Agmy
 
Corona virus
Corona virus Corona virus
Corona virus
Searchable Design
 
Corona virus
Corona virusCorona virus
Corona virus
NEELAMAGGARWAL6
 
Corona Virus nCoV (2020)
Corona Virus  nCoV (2020)Corona Virus  nCoV (2020)
Corona Virus nCoV (2020)
Deepak Saini
 
COVID-19 reviews- By Sabnam Khatun
COVID-19 reviews- By Sabnam KhatunCOVID-19 reviews- By Sabnam Khatun
COVID-19 reviews- By Sabnam Khatun
MD SHORAB ALAM
 
Corona virus ppt
Corona virus pptCorona virus ppt
Corona virus ppt
NighatKanwal
 
Swine Flu
Swine FluSwine Flu
Swine Flu
KULDEEP VYAS
 
Covid 19
Covid 19Covid 19
Covid 19
Utkarsh Sharma
 
Severe acute respiratory syndrome
Severe acute respiratory syndrome Severe acute respiratory syndrome
Severe acute respiratory syndrome
Shivangi sharma
 
Corona virus
Corona virusCorona virus
Corona virus
Sansar Babu Tiwari
 
An overview on coronavirus (COVID-19)
An overview on coronavirus (COVID-19)An overview on coronavirus (COVID-19)
An overview on coronavirus (COVID-19)
Steffi Thomas
 
Covid 19
Covid 19Covid 19
swine Flu Influenza Pptx
swine Flu Influenza Pptxswine Flu Influenza Pptx
swine Flu Influenza Pptx
Priyanka Randhir
 
Corona virus
Corona virusCorona virus
Corona virus
Ankit Mishra
 
Coronavirus disease
Coronavirus diseaseCoronavirus disease
Coronavirus disease
Megha Rani
 

What's hot (20)

COVID-19 I Coronavirus Disease I Harshit Jadav
COVID-19 I Coronavirus Disease I Harshit JadavCOVID-19 I Coronavirus Disease I Harshit Jadav
COVID-19 I Coronavirus Disease I Harshit Jadav
 
Covid 19
Covid 19Covid 19
Covid 19
 
Corona virus
Corona virusCorona virus
Corona virus
 
Corona virus COVID19
Corona virus COVID19Corona virus COVID19
Corona virus COVID19
 
COVID-19
COVID-19 COVID-19
COVID-19
 
COVID 19
COVID 19  COVID 19
COVID 19
 
Corona virus
Corona virus Corona virus
Corona virus
 
Corona virus
Corona virusCorona virus
Corona virus
 
Corona Virus nCoV (2020)
Corona Virus  nCoV (2020)Corona Virus  nCoV (2020)
Corona Virus nCoV (2020)
 
COVID-19 reviews- By Sabnam Khatun
COVID-19 reviews- By Sabnam KhatunCOVID-19 reviews- By Sabnam Khatun
COVID-19 reviews- By Sabnam Khatun
 
Corona virus ppt
Corona virus pptCorona virus ppt
Corona virus ppt
 
Swine Flu
Swine FluSwine Flu
Swine Flu
 
Covid 19
Covid 19Covid 19
Covid 19
 
Severe acute respiratory syndrome
Severe acute respiratory syndrome Severe acute respiratory syndrome
Severe acute respiratory syndrome
 
Corona virus
Corona virusCorona virus
Corona virus
 
An overview on coronavirus (COVID-19)
An overview on coronavirus (COVID-19)An overview on coronavirus (COVID-19)
An overview on coronavirus (COVID-19)
 
Covid 19
Covid 19Covid 19
Covid 19
 
swine Flu Influenza Pptx
swine Flu Influenza Pptxswine Flu Influenza Pptx
swine Flu Influenza Pptx
 
Corona virus
Corona virusCorona virus
Corona virus
 
Coronavirus disease
Coronavirus diseaseCoronavirus disease
Coronavirus disease
 

Similar to Presentation on covid 19

Coronavirus diseases
Coronavirus diseasesCoronavirus diseases
Coronavirus diseases
assam down town university
 
COVID-19: CAUSES, SYMPTOMS AND BASIC PREVENTIVE MEASURES
COVID-19: CAUSES, SYMPTOMS AND BASIC PREVENTIVE MEASURESCOVID-19: CAUSES, SYMPTOMS AND BASIC PREVENTIVE MEASURES
COVID-19: CAUSES, SYMPTOMS AND BASIC PREVENTIVE MEASURES
DrShiv Shankar
 
Uas b.ingrris
Uas b.ingrrisUas b.ingrris
Uas b.ingrris
FernandoValentine
 
Covid 19 Project-1.pptx this ppt talks about covid 19
Covid 19 Project-1.pptx this ppt talks about covid 19Covid 19 Project-1.pptx this ppt talks about covid 19
Covid 19 Project-1.pptx this ppt talks about covid 19
abiramimcc1979
 
Origin and Impact of Covid 19
Origin and Impact of Covid 19Origin and Impact of Covid 19
Origin and Impact of Covid 19
Sakshi Mishra
 
Fact and opinion about covid 19 outbreak
Fact and opinion about covid 19 outbreakFact and opinion about covid 19 outbreak
Fact and opinion about covid 19 outbreak
Titania Delfiano
 
Case study of covid 19.pdf by HARSHITHA BHARADWAJ
Case study of covid 19.pdf by HARSHITHA BHARADWAJCase study of covid 19.pdf by HARSHITHA BHARADWAJ
Case study of covid 19.pdf by HARSHITHA BHARADWAJ
prem kamal
 
Corona virus
Corona virusCorona virus
Corona virus
BhavyaSingh65
 
A Perspective Approach of Community Medicine in Corona Virus Disease COVID 19
A Perspective Approach of Community Medicine in Corona Virus Disease COVID 19A Perspective Approach of Community Medicine in Corona Virus Disease COVID 19
A Perspective Approach of Community Medicine in Corona Virus Disease COVID 19
ijtsrd
 
COVID19 - CONSUMERBEHAVIORIMPACT - AFRICA
COVID19 - CONSUMERBEHAVIORIMPACT  - AFRICACOVID19 - CONSUMERBEHAVIORIMPACT  - AFRICA
COVID19 - CONSUMERBEHAVIORIMPACT - AFRICA
MEDx eHealthCenter
 
Fact and Opinion about COVID-19 Outbreak
Fact and Opinion about COVID-19 OutbreakFact and Opinion about COVID-19 Outbreak
Fact and Opinion about COVID-19 Outbreak
YosuaLuter
 
Covid 19
Covid 19Covid 19
Covid 19
RUHIPREETKAUR
 
COVID_19 Corona virus
COVID_19 Corona virusCOVID_19 Corona virus
COVID_19 Corona virus
nosheensultan
 
Facts and Opinions about Covid-19 on how it spread and how to avoid it
Facts and Opinions about Covid-19 on how it spread and how to avoid itFacts and Opinions about Covid-19 on how it spread and how to avoid it
Facts and Opinions about Covid-19 on how it spread and how to avoid it
louisaditya09
 
Known and unknown facts you should know about covid 19
Known and unknown facts you should know about covid 19Known and unknown facts you should know about covid 19
Known and unknown facts you should know about covid 19
Muhammad Waqas
 
COVID-19- The Pandemic Outbreak
COVID-19- The Pandemic OutbreakCOVID-19- The Pandemic Outbreak
COVID-19- The Pandemic Outbreak
SonikaPawar
 
Covid 19 Awareness Series (Part 4)
Covid 19 Awareness Series (Part 4)Covid 19 Awareness Series (Part 4)
Covid 19 Awareness Series (Part 4)
SANI SINGH
 
Corona Pandemic: Precaution and Prevention
Corona Pandemic: Precaution and PreventionCorona Pandemic: Precaution and Prevention
Corona Pandemic: Precaution and Prevention
Daya Vaghani
 
Covid 19 Awareness
Covid 19 AwarenessCovid 19 Awareness
Covid 19 Awareness
ivoryleigh
 
World’s Five Most Affected Countries by COVID-19: A Comparative Study
World’s Five Most Affected Countries by COVID-19: A Comparative StudyWorld’s Five Most Affected Countries by COVID-19: A Comparative Study
World’s Five Most Affected Countries by COVID-19: A Comparative Study
International Journal of Management, Sciences, Innovation, and Technology IJMSIT
 

Similar to Presentation on covid 19 (20)

Coronavirus diseases
Coronavirus diseasesCoronavirus diseases
Coronavirus diseases
 
COVID-19: CAUSES, SYMPTOMS AND BASIC PREVENTIVE MEASURES
COVID-19: CAUSES, SYMPTOMS AND BASIC PREVENTIVE MEASURESCOVID-19: CAUSES, SYMPTOMS AND BASIC PREVENTIVE MEASURES
COVID-19: CAUSES, SYMPTOMS AND BASIC PREVENTIVE MEASURES
 
Uas b.ingrris
Uas b.ingrrisUas b.ingrris
Uas b.ingrris
 
Covid 19 Project-1.pptx this ppt talks about covid 19
Covid 19 Project-1.pptx this ppt talks about covid 19Covid 19 Project-1.pptx this ppt talks about covid 19
Covid 19 Project-1.pptx this ppt talks about covid 19
 
Origin and Impact of Covid 19
Origin and Impact of Covid 19Origin and Impact of Covid 19
Origin and Impact of Covid 19
 
Fact and opinion about covid 19 outbreak
Fact and opinion about covid 19 outbreakFact and opinion about covid 19 outbreak
Fact and opinion about covid 19 outbreak
 
Case study of covid 19.pdf by HARSHITHA BHARADWAJ
Case study of covid 19.pdf by HARSHITHA BHARADWAJCase study of covid 19.pdf by HARSHITHA BHARADWAJ
Case study of covid 19.pdf by HARSHITHA BHARADWAJ
 
Corona virus
Corona virusCorona virus
Corona virus
 
A Perspective Approach of Community Medicine in Corona Virus Disease COVID 19
A Perspective Approach of Community Medicine in Corona Virus Disease COVID 19A Perspective Approach of Community Medicine in Corona Virus Disease COVID 19
A Perspective Approach of Community Medicine in Corona Virus Disease COVID 19
 
COVID19 - CONSUMERBEHAVIORIMPACT - AFRICA
COVID19 - CONSUMERBEHAVIORIMPACT  - AFRICACOVID19 - CONSUMERBEHAVIORIMPACT  - AFRICA
COVID19 - CONSUMERBEHAVIORIMPACT - AFRICA
 
Fact and Opinion about COVID-19 Outbreak
Fact and Opinion about COVID-19 OutbreakFact and Opinion about COVID-19 Outbreak
Fact and Opinion about COVID-19 Outbreak
 
Covid 19
Covid 19Covid 19
Covid 19
 
COVID_19 Corona virus
COVID_19 Corona virusCOVID_19 Corona virus
COVID_19 Corona virus
 
Facts and Opinions about Covid-19 on how it spread and how to avoid it
Facts and Opinions about Covid-19 on how it spread and how to avoid itFacts and Opinions about Covid-19 on how it spread and how to avoid it
Facts and Opinions about Covid-19 on how it spread and how to avoid it
 
Known and unknown facts you should know about covid 19
Known and unknown facts you should know about covid 19Known and unknown facts you should know about covid 19
Known and unknown facts you should know about covid 19
 
COVID-19- The Pandemic Outbreak
COVID-19- The Pandemic OutbreakCOVID-19- The Pandemic Outbreak
COVID-19- The Pandemic Outbreak
 
Covid 19 Awareness Series (Part 4)
Covid 19 Awareness Series (Part 4)Covid 19 Awareness Series (Part 4)
Covid 19 Awareness Series (Part 4)
 
Corona Pandemic: Precaution and Prevention
Corona Pandemic: Precaution and PreventionCorona Pandemic: Precaution and Prevention
Corona Pandemic: Precaution and Prevention
 
Covid 19 Awareness
Covid 19 AwarenessCovid 19 Awareness
Covid 19 Awareness
 
World’s Five Most Affected Countries by COVID-19: A Comparative Study
World’s Five Most Affected Countries by COVID-19: A Comparative StudyWorld’s Five Most Affected Countries by COVID-19: A Comparative Study
World’s Five Most Affected Countries by COVID-19: A Comparative Study
 

More from Vipin Shukla

Teaching methodologies
Teaching methodologiesTeaching methodologies
Teaching methodologies
Vipin Shukla
 
PRIMARY EVENTS IN Photosynthesis
PRIMARY EVENTS IN PhotosynthesisPRIMARY EVENTS IN Photosynthesis
PRIMARY EVENTS IN Photosynthesis
Vipin Shukla
 
Recombinant dna guidelines(1990)
Recombinant dna guidelines(1990)Recombinant dna guidelines(1990)
Recombinant dna guidelines(1990)
Vipin Shukla
 
Site directed mutgenesis, OLIGONUCLEOTIDE DIRECTED MUTAGENESIS
Site directed mutgenesis, OLIGONUCLEOTIDE DIRECTED MUTAGENESIS Site directed mutgenesis, OLIGONUCLEOTIDE DIRECTED MUTAGENESIS
Site directed mutgenesis, OLIGONUCLEOTIDE DIRECTED MUTAGENESIS
Vipin Shukla
 
Vector & its properties and its types
Vector  & its properties and its typesVector  & its properties and its types
Vector & its properties and its types
Vipin Shukla
 
Electrophoresis
ElectrophoresisElectrophoresis
Electrophoresis
Vipin Shukla
 
World environment day
World environment dayWorld environment day
World environment day
Vipin Shukla
 
Reproductive system and its Classification
Reproductive system and its Classification Reproductive system and its Classification
Reproductive system and its Classification
Vipin Shukla
 
Excreatory system
Excreatory systemExcreatory system
Excreatory system
Vipin Shukla
 
Revised guideline for research in transgenic plants (
Revised guideline for research in transgenic plants (Revised guideline for research in transgenic plants (
Revised guideline for research in transgenic plants (
Vipin Shukla
 
Regulatory frameworks for gmo,s in india
Regulatory frameworks for gmo,s in indiaRegulatory frameworks for gmo,s in india
Regulatory frameworks for gmo,s in india
Vipin Shukla
 
Blood group determination
Blood group determinationBlood group determination
Blood group determination
Vipin Shukla
 
Approaches of biotechnology in medical
Approaches of biotechnology in medicalApproaches of biotechnology in medical
Approaches of biotechnology in medical
Vipin Shukla
 
Bio saftey in transgenics & its products
Bio saftey in transgenics & its productsBio saftey in transgenics & its products
Bio saftey in transgenics & its products
Vipin Shukla
 
Polymerase chain reaction(pcr)
Polymerase chain reaction(pcr)Polymerase chain reaction(pcr)
Polymerase chain reaction(pcr)
Vipin Shukla
 
An introduction on biosaftey
An introduction on biosafteyAn introduction on biosaftey
An introduction on biosaftey
Vipin Shukla
 
Presentation 0 n hybridoma technology
Presentation 0 n hybridoma technologyPresentation 0 n hybridoma technology
Presentation 0 n hybridoma technology
Vipin Shukla
 
Complement system.pptx2
Complement system.pptx2Complement system.pptx2
Complement system.pptx2
Vipin Shukla
 
Weismann barrier or theory
Weismann barrier or theoryWeismann barrier or theory
Weismann barrier or theory
Vipin Shukla
 
Complement system
Complement systemComplement system
Complement system
Vipin Shukla
 

More from Vipin Shukla (20)

Teaching methodologies
Teaching methodologiesTeaching methodologies
Teaching methodologies
 
PRIMARY EVENTS IN Photosynthesis
PRIMARY EVENTS IN PhotosynthesisPRIMARY EVENTS IN Photosynthesis
PRIMARY EVENTS IN Photosynthesis
 
Recombinant dna guidelines(1990)
Recombinant dna guidelines(1990)Recombinant dna guidelines(1990)
Recombinant dna guidelines(1990)
 
Site directed mutgenesis, OLIGONUCLEOTIDE DIRECTED MUTAGENESIS
Site directed mutgenesis, OLIGONUCLEOTIDE DIRECTED MUTAGENESIS Site directed mutgenesis, OLIGONUCLEOTIDE DIRECTED MUTAGENESIS
Site directed mutgenesis, OLIGONUCLEOTIDE DIRECTED MUTAGENESIS
 
Vector & its properties and its types
Vector  & its properties and its typesVector  & its properties and its types
Vector & its properties and its types
 
Electrophoresis
ElectrophoresisElectrophoresis
Electrophoresis
 
World environment day
World environment dayWorld environment day
World environment day
 
Reproductive system and its Classification
Reproductive system and its Classification Reproductive system and its Classification
Reproductive system and its Classification
 
Excreatory system
Excreatory systemExcreatory system
Excreatory system
 
Revised guideline for research in transgenic plants (
Revised guideline for research in transgenic plants (Revised guideline for research in transgenic plants (
Revised guideline for research in transgenic plants (
 
Regulatory frameworks for gmo,s in india
Regulatory frameworks for gmo,s in indiaRegulatory frameworks for gmo,s in india
Regulatory frameworks for gmo,s in india
 
Blood group determination
Blood group determinationBlood group determination
Blood group determination
 
Approaches of biotechnology in medical
Approaches of biotechnology in medicalApproaches of biotechnology in medical
Approaches of biotechnology in medical
 
Bio saftey in transgenics & its products
Bio saftey in transgenics & its productsBio saftey in transgenics & its products
Bio saftey in transgenics & its products
 
Polymerase chain reaction(pcr)
Polymerase chain reaction(pcr)Polymerase chain reaction(pcr)
Polymerase chain reaction(pcr)
 
An introduction on biosaftey
An introduction on biosafteyAn introduction on biosaftey
An introduction on biosaftey
 
Presentation 0 n hybridoma technology
Presentation 0 n hybridoma technologyPresentation 0 n hybridoma technology
Presentation 0 n hybridoma technology
 
Complement system.pptx2
Complement system.pptx2Complement system.pptx2
Complement system.pptx2
 
Weismann barrier or theory
Weismann barrier or theoryWeismann barrier or theory
Weismann barrier or theory
 
Complement system
Complement systemComplement system
Complement system
 

Recently uploaded

Orion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWSOrion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWS
Columbia Weather Systems
 
Nutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technologyNutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technology
Lokesh Patil
 
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Ana Luísa Pinho
 
DMARDs Pharmacolgy Pharm D 5th Semester.pdf
DMARDs Pharmacolgy Pharm D 5th Semester.pdfDMARDs Pharmacolgy Pharm D 5th Semester.pdf
DMARDs Pharmacolgy Pharm D 5th Semester.pdf
fafyfskhan251kmf
 
extra-chromosomal-inheritance[1].pptx.pdfpdf
extra-chromosomal-inheritance[1].pptx.pdfpdfextra-chromosomal-inheritance[1].pptx.pdfpdf
extra-chromosomal-inheritance[1].pptx.pdfpdf
DiyaBiswas10
 
bordetella pertussis.................................ppt
bordetella pertussis.................................pptbordetella pertussis.................................ppt
bordetella pertussis.................................ppt
kejapriya1
 
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Sérgio Sacani
 
Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...
Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...
Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...
Studia Poinsotiana
 
原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样
原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样
原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样
yqqaatn0
 
S.1 chemistry scheme term 2 for ordinary level
S.1 chemistry scheme term 2 for ordinary levelS.1 chemistry scheme term 2 for ordinary level
S.1 chemistry scheme term 2 for ordinary level
ronaldlakony0
 
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptxBody fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
muralinath2
 
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdfUnveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Erdal Coalmaker
 
erythropoiesis-I_mechanism& clinical significance.pptx
erythropoiesis-I_mechanism& clinical significance.pptxerythropoiesis-I_mechanism& clinical significance.pptx
erythropoiesis-I_mechanism& clinical significance.pptx
muralinath2
 
GBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture MediaGBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture Media
Areesha Ahmad
 
role of pramana in research.pptx in science
role of pramana in research.pptx in sciencerole of pramana in research.pptx in science
role of pramana in research.pptx in science
sonaliswain16
 
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
Sérgio Sacani
 
general properties of oerganologametal.ppt
general properties of oerganologametal.pptgeneral properties of oerganologametal.ppt
general properties of oerganologametal.ppt
IqrimaNabilatulhusni
 
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATIONPRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
ChetanK57
 
Toxic effects of heavy metals : Lead and Arsenic
Toxic effects of heavy metals : Lead and ArsenicToxic effects of heavy metals : Lead and Arsenic
Toxic effects of heavy metals : Lead and Arsenic
sanjana502982
 
DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...
DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...
DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...
Wasswaderrick3
 

Recently uploaded (20)

Orion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWSOrion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWS
 
Nutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technologyNutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technology
 
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
 
DMARDs Pharmacolgy Pharm D 5th Semester.pdf
DMARDs Pharmacolgy Pharm D 5th Semester.pdfDMARDs Pharmacolgy Pharm D 5th Semester.pdf
DMARDs Pharmacolgy Pharm D 5th Semester.pdf
 
extra-chromosomal-inheritance[1].pptx.pdfpdf
extra-chromosomal-inheritance[1].pptx.pdfpdfextra-chromosomal-inheritance[1].pptx.pdfpdf
extra-chromosomal-inheritance[1].pptx.pdfpdf
 
bordetella pertussis.................................ppt
bordetella pertussis.................................pptbordetella pertussis.................................ppt
bordetella pertussis.................................ppt
 
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
 
Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...
Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...
Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...
 
原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样
原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样
原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样
 
S.1 chemistry scheme term 2 for ordinary level
S.1 chemistry scheme term 2 for ordinary levelS.1 chemistry scheme term 2 for ordinary level
S.1 chemistry scheme term 2 for ordinary level
 
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptxBody fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
 
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdfUnveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdf
 
erythropoiesis-I_mechanism& clinical significance.pptx
erythropoiesis-I_mechanism& clinical significance.pptxerythropoiesis-I_mechanism& clinical significance.pptx
erythropoiesis-I_mechanism& clinical significance.pptx
 
GBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture MediaGBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture Media
 
role of pramana in research.pptx in science
role of pramana in research.pptx in sciencerole of pramana in research.pptx in science
role of pramana in research.pptx in science
 
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
 
general properties of oerganologametal.ppt
general properties of oerganologametal.pptgeneral properties of oerganologametal.ppt
general properties of oerganologametal.ppt
 
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATIONPRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
 
Toxic effects of heavy metals : Lead and Arsenic
Toxic effects of heavy metals : Lead and ArsenicToxic effects of heavy metals : Lead and Arsenic
Toxic effects of heavy metals : Lead and Arsenic
 
DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...
DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...
DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...
 

Presentation on covid 19

  • 1. Prepared By: Vipin Kr. Shukla Assistant Lecturer Presentation on COVID-19
  • 2. Introduction of COVID-19:  It is the infectious and communicable disease caused by the newly developed virus CORONA (COVID-19), which is characterized by flu, cough, sore throat, fever, severe acute respiratory syndrome and pneumonia.  COVID-19 is a disease caused by a type of corona virus called “ Sars Cov2”.  The name corona came from its crown like structure called “Spike Protein”.  The Virus uses the spike protein to infect human cells.
  • 3. Contd….  Corona viruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome.  (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV).  A novel corona virus (nCoV) is a new strain that has not been previously identified in humans
  • 4. Origin Wuhan City, Hubei Province, China.
  • 6. Causes:  The main cause of this disease is newly developed virus CORONA, COVID-19 virus.  The name corona virus comes from the Latin word corona, meaning crown or halo.  Under an electron microscope, the looks like it is surrounded by a solar corona.  First time COVID-19 discovered in a seafood and poultry market in the Chinese city of Wuhan in 2019.
  • 8.
  • 9. Mode of transmission:  COVID-19 transmitted through respiratory droplet and 2-14 days estimated incubation period.  Humans first get a corona virus from contact with animals. Then, it can spread from human to human.  Health officials do not know what animal caused COVID -19  The COVID-19 virus can be spread through contact with certain body fluids, such as droplets in cough.  It might also be caused by touching something an infected person has touched and then touching your hand to your mouth, nose or eyes.
  • 11. People who are at higher risk:  People aged 65 years and older.  People who live in a nursing home or long-term care facility.  Other high-risk conditions could include:  People with chronic lung disease or moderate to severe asthma  People who have serious heart conditions  People who are immuno-compromised including cancer treatment, smoking, bone marrow or organ.  transplantation, immune deficiencies, poorly controlled HIV or AIDS, and prolonged use of corticosteroids and other immune weakening medications.
  • 12. WHY IT IS TERMED AS PANDEMIC?? On March 11, 2020 WHO announced COVID- 19 as a pandemic which indicated that the spread of this novel virus has become a worldwide phenomenon, which has infected almost 200 countries and territories around the world including INDIA and there are almost 2,407,699 confirmed cases of coronavirus COVID-19.
  • 13. PREVENTION--- WHAT TO DO???  Wash your hands often with soap and water for 20 seconds.  Use a hand sanitizer (at least 70% alcohol based) if soap and water are not available and cover all the surfaces of your hands.  DO USE a handkerchief or a tissue to cover your face while coughing or sneezing.  DO THROW the used tissue immediately into a closed dustbin.
  • 14. Do cover your sneeze into your bent arm in case you are not carrying a tissue or a handkerchief. Do wash hands immediately after you have covered your sneeze or cough with your hands.
  • 15. Stay at home unless absolutely necessary. Keep a distance of at least one meter between yourself and another person.
  • 16. WHAT NOT TO DO??? Do not touch your eyes, nose and mouth with unwashed hands. Do not touch surfaces like door knobs, door bells, elevator button, handrails etc. Do not spit in open, always use a spittoon or wash basin for spitting. Do not go to crowded places like markets, shopping, fairs, parties. Do not use public transport. Do not hold events where people have to gather.
  • 17. High Risk: People who have underlying medical conditions like: • Diabetes. • Heart Disease. • Lung Disease. • Kidney Disease. • Cancer Medication Pregnant Women (as we don’t know the impact of the disease on Pregnancy, it is better to take care
  • 18. MYTHS AND FACTS…  Statement: With the summers coming up, the Corona virus will be killed.  FACT: COVID-19 has been detected in ALL AREAS, including areas with hot and humid weather. The best way to protect yourself against COVID- 19 is by frequently washing your hands with soap and water, covering your coughs and sneezes and avoiding crowded places.  Statement: Having a bath with hot water will kill the virus.  FACT: The virus lives inside the body where the temperature is maintained at 37ºC and is not affected by a hot water bath that you have.  Statement: Getting the pneumonia vaccine will protect you against the virus.  FACT: While vaccines for Pneumonia will certainly protect you against other organisms that cause pneumonia, The vaccine for Novel Corona virus is under development.
  • 19. Contd….  Statement: Regularly rinsing the nose with saline will prevent the infection.  FACT: Rinsing nose with saline has in few cases helped in containing common cold, but has no evidence to suggest it is effective against the Novel Corona virus infection.  Statement: Corona virus can be passed through chicken and meat.  FACT: No! There is no such evidence of Corona virus spreading through meat and poultry products. However it is always advised to have properly cooked meat and chicken.
  • 20. Contd….  Statement: Eating raw garlic, sesame seeds will protect you against the virus.  FACT: Garlic is a healthy food that has other benefits but does not protect you against the Corona virus.  Statement: You can get COVID-19 through mosquito bites.  FACT: The Corona virus cannot be spread through the bite of a mosquito. It is spread thorough droplets spread when an infected person sneezes or coughs.
  • 21. Some other consequences of COVID-19:  STIGMA  DISCRIMINATION  DEPRESSION
  • 22. Why there is stigma??  The level of stigma associated with COVID-19 is based on three main factors:  COVID-19 is a new disease about which many things are still being discovered.  When something is unknown people are worried which leads to fear.  Rumors or fake news give wrong information and spreads the fear.
  • 24. It is the time not to be afraid but need to get aware… Follow all the advices either prescribed by the health department or by the government… Be a responsible citizen. Stay At Home, Stay Safe, Stay Healthy and Happy…
  • 25. Most Important Points….  Always Be Positive.  Do not preach or give news that is not confirmed.  Always be polite. Anyone can get the infection. Do not discriminate, shout, or use rude language.  Stay away from watching negative things on TV and also fake news.  Engage in relaxing activities like indoor games, reading, gardening, home-cleaning etc.  Do Meditation, pray to GOD and spend some time with yourself also.
  • 26. Some great persons said… So powerful is the light of unity that it can illuminate the whole earth. Even the weak become strong when they are united. So to beat this worldwide pandemic, we all have to come together and fulfill our respective responsibilities.
  • 28. Recent news on vaccine:  India has so far approved three vaccines against the deadly COVID-19 to be used for its inoculation drive which started on January 16.  The three vaccines approved by the Health Ministry are Serum Institute of India's (SII) Covishield, Bharat Biotech's Covaxin and Russia's Sputnik V.  While Covaxin and Covishield are available since the vaccination drive started in January, Russia's Sputnik V got the government's approval last week and will now be distributed by Dr Reddy’s Laboratories in India. With this, Sputnik V also became the second most expensive COVID-19 vaccine available in the country.
  • 29. ….  University and pharma major AstraZeneca, the Covaxin has been developed by India's Bharat Biotech in association with the Indian Council of Medical Research (ICMR).  The Sputnik V has been developed by Moscow-based Gamaleya Research Institute of Epidemiology and Microbiology, and like most vaccines, it also needs to be administered in two doses.  As the world's biggest vaccination drive is underway, there is a lot of buzzes that surrounds the use of the vaccines, it's efficacy and possible side effects.  We at Jagran English bring you some noteworthy differences between the three vaccines available in India you must be aware of.
  • 30. Introduction:  A COVID-19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), the virus causing corona virus disease 2019 (COVID-19).  Prior to the COVID-19 pandemic, there was an established body of knowledge about the structure and function of corona viruses causing diseases like severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), which enabled accelerated development of various vaccine technologies during early 2020.
  • 31. Contd….  On 10 January 2020, the SARS-CoV-2 genetic sequence data was shared through GISAID and by 19 March, the global pharmaceutical industry announced a major commitment to address COVID-19.  Since January 2020, vaccine development has been expedited via unprecedented collaboration in the multinational pharmaceutical industry and between governments.
  • 32. Contd….  According to the Coalition for Epidemic Preparedness Innovations (CEPI),  the geographic distribution of COVID-19 vaccine development puts North American entities having about 40% of the activity compared to 30% in Asia and Australia, 26% in Europe, and a few projects in South America and Africa.  As of January 2021, nine different technology platforms – with the technology of numerous candidates remaining undefined – are under research and development to create an effective vaccine against COVID-19.  Most of the platforms of vaccine candidates in clinical trials are focused on the corona virus spike protein and its variant as the primary antigen of COVID-19 infection.  Platforms being developed in 2020 involved nucleic acid technologies (nucleoside- modified messenger RNA and DNA non-replicating viral vectors, peptides, recombinant proteins, live attenuated viruses, and inactivated viruses.
  • 33. Types of Vaccines:  An RNA vaccine contains RNA which, when introduced into a tissue, acts as messenger RNA (mRNA) to cause the cells to build the foreign protein and stimulate an adaptive immune response which teaches the body how to identify and destroy the corresponding pathogen or cancer cells.  RNA vaccines often, but not always, use nucleoside-modified messenger RNA.  The delivery of mRNA is achieved by a co formulation of the molecule into lipid nanoparticles which protect the RNA strands and help their absorption into the cells.
  • 34. Comparison Between Covaxin & Covishield:
  • 35.
  • 36.
  • 38. WHO CAN REGISTER?  Senior Citizens (age 60+).  People with co- morbidities (age 45 to 59).  18+ Individuals.
  • 39. WHAT’S THE COST?  People walking in private health facilities – INR 250/-  includes syringe.  Needle.  Fees for National Health Accounts Govt of India.  Govt Centers: Free of Cost.
  • 40. Contd….  PRE-REQUISITES:  Co-Win App  Aarogya Setu App  Way to logon to cowin.gov.in  Doctors certificate in case of Co-morbidities
  • 41. Step By Step Guide for Registration:  Open one of the below  Co-Win App.  Aarogya Setu App.  visit www.cowin.gov.in.  Enter your mobile number.  You will receive OTP i.e. One Time Password on your mobile.  Create account using OTP.  Fill below details:  Name.  Age.  Gender.  Identification proof.  Doctors certificate in case of co-morbidities & age 45 to 59.  Choose your vaccine centre & Date.
  • 42.
  • 43.
  • 44. Covishield Vs Covaxin:  The interval between 1st and 2nd doses is 12-16 weeks.  Efficacy after the second dose can vary from 70-90%.  People above 18 years of age can opt for this vaccine.  Covishield is less expensive. SII is selling this vaccine at INR 300 (government) and INR 600 (private centers).  Covishield is more easily available  The interval between the 2 doses is 4-6 weeks.  This vaccine can be 78-100% effective after the second dose.  This vaccine can be injected into younger people as well (12 years and above).  Covaxin is more expensive and is being sold at INR 400 (government) and INR 1200 (private facilities).  Fewer hospitals and healthcare centers are stocking Covaxin